Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Wijaya Karya Bangunan Gedung Tbk. (WEGE)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Wijaya Karya Bangunan Gedung Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Wijaya Karya Bangunan Gedung Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 488,17 M, volume 24 jam 44,92 jt). Perbedaan utamanya: Wijaya Karya Bangunan Gedung Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WEGE | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 488,17 M |
Volume | — | 44,92 jt |
Lot | — | 449,16 rb |
Perputaran | — | 2,25 M |
Harga Rata-rata | — | 50,18 |
Nilai Transaksi | — | 2,25 M |
Harga Ekuilibrium Indikatif | — | 50 |
Volume Ekuilibrium Indikatif | — | 3,49 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Wijaya Karya Bangunan Gedung Tbk.
PT Wijaya Karya Bangunan Gedung Tbk (the Company) is located in South Jakarta, DKI Jakarta was established by Deed No. 43, October 24, 2008 made before Imas Fatimah, SH., Notary in Jakarta.
Selengkapnya di halaman WEGE →
